NCT00465621已完成2 期
Dose Response Study of AL-37807 Ophthalmic Solution in Patients With Open-Angle Glaucoma or Ocular Hypertension
适应症
相关药物
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 入组人数
- 150
- 试验地点
- 2
- 主要终点
- Mean IP Change from Baseline
研究概览
简要总结
The purpose of thie study is to compare the safety and IOP-lowering efficacy of AL-37807 Ophthalmic Solution 0.05%, 0.1% and 0.2% dosed QD AM to Xalatan dosed QD PM and Vehicle in patients with open-angle glaucoma or ocular hypertension
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Single Group
- 主要目的
- Treatment
- 盲法
- Double
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Open-angle glaucoma
- •ocular hypertension
排除标准
- •VA worse than 0.60
结局指标
主要结局
Mean IP Change from Baseline
次要结局
未报告次要终点
研究者
研究点 (2)
Loading locations...
相似试验
已完成
2 期
Adjunctive Study of AL-37807 Ophthalmic SuspensionOcular HypertensionOpen-Angle GlaucomaNCT00620256Alcon Research129
已完成
2 期
A Study of AL-38583 Ophthalmic Solution 0.05%, 0.010% Versus AL-38583 Vehicle for Dry EyeDry EyeNCT00893139Alcon Research765
已完成
2 期
24 Hour IOP Lowering Efficacy of AL-3789Open-angle GlaucomaNCT00643669Alcon Research25
已完成
2 期
Safety and Efficacy of Anecortave Acetate in Patients With Open-Angle GlaucomaOpen-angle GlaucomaNCT00451152Alcon Research89
已完成
2 期
Anecortave Acetate Safety in Patients With Open-Angle Glaucoma or Ocular HypertensionOular HypertensionOpen-angle GlaucomaNCT00691717Alcon Research201